Frank F. Dolan is a distinguished entrepreneur and expert in the life sciences and biotech industries, with a career spanning over two decades. As the founder of Arsenal Life Science, a consulting firm established in 2018, Frank has become a pivotal figure in biotech commercialization. His expertise has led to the successful launch of 15 major products, including the renowned pharmaceutical brand Lipitor. Frank's strategic vision and leadership have significantly enhanced company valuations, contributing to acquisitions totaling over $100 billion.A passionate patient advocate, Frank is committed to fostering innovations that not only advance the industry but also enhance global well-being. His work is driven by a belief in the power of science and technology to create a healthier, thriving world. Frank's influence extends beyond business achievements; he is a recognized thought leader who frequently shares his insights at industry conferences and through publications.Based in Moldova, Frank also engages with entrepreneurial communities, such as MassChallenge, to mentor up-and-coming leaders in the biotech sector. His dedication to both business excellence and societal progress defines his multifaceted career and enduring impact on the life sciences landscape.